HK1028547A1 - Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols. - Google Patents

Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols.

Info

Publication number
HK1028547A1
HK1028547A1 HK00106846A HK00106846A HK1028547A1 HK 1028547 A1 HK1028547 A1 HK 1028547A1 HK 00106846 A HK00106846 A HK 00106846A HK 00106846 A HK00106846 A HK 00106846A HK 1028547 A1 HK1028547 A1 HK 1028547A1
Authority
HK
Hong Kong
Prior art keywords
carnitine
alkanoyl
long
chain alkanols
composition
Prior art date
Application number
HK00106846A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1028547A1 publication Critical patent/HK1028547A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
HK00106846A 1997-08-01 2000-10-26 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols. HK1028547A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000487A IT1294227B1 (it) 1997-08-01 1997-08-01 Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
PCT/IT1998/000190 WO1999006039A1 (fr) 1997-08-01 1998-07-09 Composition comprenant de la l-carnitine ou une l-carnitine d'alcanoyle et des alcanols a chaine longue

Publications (1)

Publication Number Publication Date
HK1028547A1 true HK1028547A1 (en) 2001-02-23

Family

ID=11405212

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106846A HK1028547A1 (en) 1997-08-01 2000-10-26 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols.

Country Status (16)

Country Link
US (1) US6328998B1 (fr)
EP (1) EP0999832B1 (fr)
JP (1) JP4295429B2 (fr)
KR (1) KR100530878B1 (fr)
AT (1) ATE277611T1 (fr)
AU (1) AU741363B2 (fr)
CA (1) CA2295746C (fr)
DE (1) DE69826674T2 (fr)
DK (1) DK0999832T3 (fr)
ES (1) ES2229514T3 (fr)
HK (1) HK1028547A1 (fr)
IT (1) IT1294227B1 (fr)
NZ (1) NZ501967A (fr)
PT (1) PT999832E (fr)
SI (1) SI0999832T1 (fr)
WO (1) WO1999006039A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306178B1 (it) 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
US20060166951A1 (en) * 2002-05-31 2006-07-27 Archer-Daniels-Midland Company Compositions and methods for sterol isolation and purification
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
AU2003241477A1 (en) 2002-06-10 2003-12-22 Elan Pharma International, Ltd. Nanoparticulate polycosanol formulations and novel polycosanol combinations
EP1515714B1 (fr) * 2002-06-17 2009-08-12 Medestea Research & Production S.p.A. Composes oxygenes insatures a chaine longue et leur utilisation dans le domaine therapeutique, cosmetique et nutraceutique
US20090196914A1 (en) * 2002-11-14 2009-08-06 Optime Therapeutics, Inc. Liposomal l-carnitine
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040327A1 (it) * 2004-07-01 2004-10-01 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
US7615641B2 (en) * 2004-07-20 2009-11-10 Sino Pharmaceuticals Corporation Long chain aliphatic alcohol derivatives and methods of making and using same
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
PE20200747A1 (es) 2017-08-14 2020-07-24 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
JPS6299323A (ja) * 1985-10-25 1987-05-08 Yoshihide Hagiwara 高脂血症剤
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury
DE69026496D1 (de) * 1989-10-13 1996-05-15 Neurofit Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
JPH05103629A (ja) * 1991-10-11 1993-04-27 Yukio Yanagimoto 体力増強剤
JPH05103596A (ja) * 1991-10-11 1993-04-27 Yukio Yanagimoto 陸上動物用体力増強剤及び陸上動物用飼料
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH05310563A (ja) * 1992-05-15 1993-11-22 Nippon Oil & Fats Co Ltd カルシトニン産生増強剤
JPH0825891B2 (ja) * 1993-06-25 1996-03-13 株式会社薬理学中央研究所 脱脂米胚芽由来のリパーゼインヒビター
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi

Also Published As

Publication number Publication date
ES2229514T3 (es) 2005-04-16
AU741363B2 (en) 2001-11-29
EP0999832B1 (fr) 2004-09-29
ITRM970487A1 (it) 1999-02-01
SI0999832T1 (en) 2004-12-31
KR20010022449A (ko) 2001-03-15
US6328998B1 (en) 2001-12-11
EP0999832A1 (fr) 2000-05-17
AU8240798A (en) 1999-02-22
ATE277611T1 (de) 2004-10-15
CA2295746A1 (fr) 1999-02-11
KR100530878B1 (ko) 2005-11-23
PT999832E (pt) 2004-12-31
DK0999832T3 (da) 2005-01-17
JP4295429B2 (ja) 2009-07-15
WO1999006039A1 (fr) 1999-02-11
JP2001511447A (ja) 2001-08-14
NZ501967A (en) 2001-09-28
DE69826674D1 (de) 2004-11-04
IT1294227B1 (it) 1999-03-24
DE69826674T2 (de) 2005-02-24
CA2295746C (fr) 2007-11-20

Similar Documents

Publication Publication Date Title
HK1028547A1 (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols.
CA2191645A1 (fr) Composition pharmaceutique renfermant de la l-carnitine ou de la l-carnitine alcanoylee en combinaison avec un acide gras polyinsature de la serie omega-3 pour la prevention et letraitement des troubles du metabolisme des lipides
CA2086429A1 (fr) Composition pharmaceutique ou cosmetique contenant en association un retinoide et un sterol
ZA9610508B (en) Pharmaceutical composition comprising l-carnitine or alkanoyl l-carnitine for the prevention and treatment of diseases brought about by lipid metabolism disorders
BG102733A (en) New substituted cyclic amino acids as pharmaceutical forms
EP1520582A3 (fr) Utilisation d'inhibiteurs de la dipeptidylpeptidase pour réguler le métabolisme du glucose
BR9810121A (pt) Utilização do acido petroselìnico nativo ou esterificado
CA2273298A1 (fr) Produit et methode de traitement de l'hyperlipidemie
GEP20001898B (en) Method and Pharmaceutical Composition for Regulating Lipid Concentration with Mam
AU2192395A (en) Novel cationic phospholipids for transfection
BG109876A (en) APPLICATION OF L-CARNITIN ESTERS OR ALCANAILIC L-CARNITINES AS CATIONARY LIPIDS FOR INTRACULAR TRANSMISSION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
PE20001325A1 (es) Combinacion de cerivastatina y fibratos
EP0795604A3 (fr) Souches de bactéries avec du métabolisme d'acides biliaires modifié et leur utilisation
EP1623708A3 (fr) Composition pharmaceutique conténant de l'acétyl-L-carnitine et une statine pour le traitement des pathologies associés avec une altération du métabolisme des gras
IT1307278B1 (it) Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil
ES2099676A1 (es) Nuevo producto de fibra de cacao a base de cascara de cacao tostada.
BG104119A (en) A new composition
NZ298141A (en) Treating lipid metabolism disorder using TCF-II
PT1010429E (pt) Composicao farmaceutica em particular para uso dietetico constituida por um derivado de acido piruvico e extracto de laranja amarga nao madura
ECSP972296A (es) Sintesis de benzo (f) quinolinonas
BR7700881U (pt) Papa pizza
AR009470A1 (es) COMPOSICIoN FARMACÉUTICA QUE CONTIENE CEPAS BACTERIANAS Y UTILES EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS CON O CAUSADAS POR ALTERACIONES EN EL METABOLISMO DE LOS ÁCIDOS BILIARES, Y USO DE LAS MISMAS.
FR2748643B1 (fr) Presentoir, avec socle amovible, notamment pour la commercialisation de livres et cassettes, ainsi que le flan necessaire

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150709